Backlash prompts company to lower price of drug used to treat cancer, AIDS

Backlash prompts company to lower price of drug used to treat cancer, AIDS

Backlash about an exorbitant increase in a drug used to treat symptoms of cancer and AIDS has prompted the company who bought the rights to Daraprim to lower the price.